Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study

per Ganguli, Rohan, Brar, Jaspreet S, Mahmoud, Ramy, Berry, Sally A, Pandina, Gahan J
Publicat 2008

NWP06, an Extended-Release Oral Suspension of Methylphenidate, Improved Attention-Deficit/Hyperactivity Disorder Symptoms Compared with Placebo in a Laboratory Classroom Study

per Wigal, Sharon B., Childress, Ann C., Belden, Heidi W., Berry, Sally A.
Publicat 2013

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder

per Wigal, Sharon B., Childress, Ann, Berry, Sally A., Belden, Heidi, Walters, Faith, Chappell, Phillip, Sherman, Nancy, Orazem, John, Palumbo, Donna
Publicat a J Child Adolesc Psychopharmacol (2017)

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

per Childress, Ann C., Wigal, Sharon B., Brams, Matthew N., Turnbow, John M., Pincus, Yulia, Belden, Heidi W., Berry, Sally A.
Publicat a J Child Adolesc Psychopharmacol (2018)

Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study

per Wigal, Sharon B., Childress, Ann, Berry, Sally A., Belden, Heidi W., Chappell, Phillip, Wajsbrot, Dalia B., Nagraj, Praneeta, Abbas, Richat, Palumbo, Donna
Publicat a J Child Adolesc Psychopharmacol (2018)

Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia

per Ader, Marilyn, Garvey, W. Timothy, Phillips, Lawrence S., Nemeroff, Charles B., Gharabawi, Georges, Mahmoud, Ramy, Greenspan, Andrew, Berry, Sally A., Musselman, Dominique L., Morein, Jacqueline, Zhu, Young, Mao, Lian, Bergman, Richard N.
Publicat 2008